ASCO 2019: High-risk prostate cancer: 10 year results after image guided intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost
Christian Ekanger | ASCO 2019 | Juni 5, 2019
Speaker: Christian Ekanger
10 year results show that high-risk prostate cancer patients treated with image guided intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost obtained favorable outcomes with few serious side effects. Hear Christian Ekanger present the results.